Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Indian pharma, healthcare sector poised for another year of robust growth

      Indian pharma, healthcare sector poised for another year of robust growth

      Medical Dialogues Bureau30 Dec 2019 9:30 AM IST
      "The Indian Pharmaceutical industry is a sunrise industry with a competitive advantage for India. We should leverage India's position by unleashing...
      Flexion Therapeutics gets USFDA nod to update product label for Zilretta to treat osteoarthritis knee pain

      Flexion Therapeutics gets USFDA nod to update product label for Zilretta to treat osteoarthritis knee pain

      Medical Dialogues Bureau30 Dec 2019 9:15 AM IST
      New Delhi: Flexion Therapeutics, Inc recently announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug...
      Antibiotics maker Melinta files for bankruptcy protection

      Antibiotics maker Melinta files for bankruptcy protection

      Medical Dialogues Bureau30 Dec 2019 9:00 AM IST
      Larger drugmakers, including AstraZeneca Plc, Novartis and Sanofi SA, have stopped developing antibiotics, while smaller players such as Achaogen Inc...
      Department of Pharmaceuticals to hire Technical Consultants on contract basis; Details

      Department of Pharmaceuticals to hire Technical Consultants on contract basis; Details

      Medical Dialogues Bureau29 Dec 2019 12:10 PM IST
      New Delhi: Through a recent release, the Department of Pharmaceuticals (DoP) has informed about the hiring of Technical Consultants in the department...
      Siddhivinayak Trust to provide Rs 10 crore for pneumococcal vaccination drive

      Siddhivinayak Trust to provide Rs 10 crore for pneumococcal vaccination drive

      Medical Dialogues Bureau29 Dec 2019 9:20 AM IST
      The Shree Siddhivinayak Ganapati Temple Trust has sanctioned Rs 10 crore for the Maharashtra government’s drive of giving pneumococcal vaccines to the...
      OBI Pharma gets USFDA clearance for OBI-999 to treat pancreatic cancer

      OBI Pharma gets USFDA clearance for OBI-999 to treat pancreatic cancer

      Medical Dialogues Bureau29 Dec 2019 9:15 AM IST
      New Delhi: OBI Pharma, a Taiwan biopharma company, recently announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational...
      Luye Pharma seeks USFDA nod for antidepressant drug LY03005

      Luye Pharma seeks USFDA nod for antidepressant drug LY03005

      Medical Dialogues Bureau29 Dec 2019 9:00 AM IST
      New Delhi: Luye Pharma Group has announced that the New Drug Application (NDA) for Risperidone Extended-Release Microspheres for Injection (LY03004),...
      Towa Pharma to acquire ESTEVE generic division Pensa Investments for 320 million euros

      Towa Pharma to acquire ESTEVE generic division Pensa Investments for 320 million euros

      Medical Dialogues Bureau28 Dec 2019 9:15 AM IST
      The purchase price of Pensa will be an all-cash deal with an upfront payment of 320 million euros. This acquisition is scheduled to be completed by...
      Spring Bank Pharma halts dosing of Inarigivir patients in phase-2 trial to treat chronic HBV

      Spring Bank Pharma halts dosing of Inarigivir patients in phase-2 trial to treat chronic HBV

      Medical Dialogues Bureau28 Dec 2019 9:00 AM IST
      New Delhi: Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
      Granules India Independent Director C Parthasarathy resigns

      Granules India Independent Director C Parthasarathy resigns

      Medical Dialogues Bureau27 Dec 2019 3:55 PM IST
      C Parthasarathy was serving the company since May 27, 2009. However, he submitted his resignation from the Board of Governors of Granules India Ltd....
      Lupin Ankleshwar facility wins India Manufacturing Excellence Awards 2019

      Lupin Ankleshwar facility wins India Manufacturing Excellence Awards 2019

      Medical Dialogues Bureau27 Dec 2019 9:30 AM IST
      The 2019 evaluation was done on the basis of an organisations’ Manufacturing Capability, Extended Supply Chain Reliability and Technology Adoption,...
      Correvio Pharma heart drug Brinavess fails to get USFDA nod

      Correvio Pharma heart drug Brinavess fails to get USFDA nod

      Medical Dialogues Bureau27 Dec 2019 9:22 AM IST
      In the so-called complete response letter, the USFDA stated that while the submitted data provide substantial evidence of the drug's effectiveness,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok